Sergei I Luyksaar (S I Luyksaar, Sergey I Luyksaar)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Multidrug Resistant

Cell Cycle Arrest

Respiratory Syndrome Coronavirus

Biofilm Formation

Top Venues

Pharmaceuticals (Basel, Switzerland)

The Journal of antibiotics

BioMed research international

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Elizaveta S Darnotuk, Andrei E Siniavin, Natal'ya S Shastina, Sergei I Luyksaar, Anna M Inshakova, Natalia E Bondareva, Sergey A Zolotov, Nadezhda L Lubenec, Anna B Sheremet, Denis Y Logunov, Nailya A Zigangirova, Vladimir A Gushchin, Alexander L Gintsburg
Synthesis and Antiviral Activity of Novel β-D-N4-Hydroxycytidine Ester Prodrugs as Potential Compounds for the Treatment of SARS-CoV-2 and Other Human Coronaviruses. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Elizaveta S Darnotuk, Andrei E Siniavin, Natal'ya S Shastina, Sergei I Luyksaar, Anna M Inshakova, Natalia E Bondareva, Sergey A Zolotov, Nadezhda L Lubenec, Anna B Sheremet, Denis Y Logunov, Nailya A Zigangirova, Vladimir A Gushchin, Alexander L Gintsburg
Synthesis and Antiviral Activity of Novel β-D-N4-Hydroxycytidine Ester Prodrugs as Potential Compounds for the Treatment of SARS-CoV-2 and Other Human Coronaviruses. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
E A Koroleva, A V Soloveva, E Y Morgunova, L N Kapotina, Sergei I Luyksaar, S V Luyksaar, Nataliya E Bondareva, S A Nelubina, N L Lubenec, N A Zigangirova, A L Gintsburg
Fluorothiazinon inhibits the virulence factors of uropathogenic Escherichia coli involved in the development of urinary tract infection. The Journal of antibiotics (2023)
Elizaveta S Darnotuk, Andrei E Siniavin, Natal'ya S Shastina, Sergei I Luyksaar, Anna M Inshakova, Natalia E Bondareva, Sergey A Zolotov, Nadezhda L Lubenec, Anna B Sheremet, Denis Y Logunov, Nailya A Zigangirova, Vladimir A Gushchin, Alexander L Gintsburg
Synthesis and Antiviral Activity of Novel β-D-N4-Hydroxycytidine Ester Prodrugs as Potential Compounds for the Treatment of SARS-CoV-2 and Other Human Coronaviruses. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Andrei E Siniavin, Mikhail S Novikov, Vladimir Alexeyevich Gushchin, Alexander A Terechov, Igor A Ivanov, Maria P Paramonova, Elena S Gureeva, Leonid I Russu, Nadezhda A Kuznetsova, Elena V Shidlovskaya, Sergei I Luyksaar, Daria V Vasina, Sergei A Zolotov, Nailya A Zigangirova, Denis Y Logunov, Alexander L Gintsburg
Antiviral Activity of N 1 ,N 3 -Disubstituted Uracil Derivatives against SARS-CoV-2 Variants of Concern. International journal of molecular sciences 23 (17) (2022)
Nataliya E Bondareva, Anna V Soloveva, Anna B Sheremet, Ekaterina A Koroleva, Lidiya N Kapotina, Elena Y Morgunova, Sergei I Luyksaar, Egor S Zayakin, Nailya A Zigangirova
Preventative treatment with Fluorothiazinon suppressed Acinetobacter baumannii-associated septicemia in mice. The Journal of antibiotics 75 (3) (2022)
Anna B Sheremet, Naylia A Zigangirova, Egor S Zayakin, Sergei I Luyksaar, Lydia N Kapotina, Ludmila N Nesterenko, Natalie V Kobets, Alexander L Gintsburg
Small Molecule Inhibitor of Type Three Secretion System Belonging to a Class 2,4-disubstituted-4H-[1,3,4]-thiadiazine-5-ones Improves Survival and Decreases Bacterial Loads in an Airway Pseudomonas aeruginosa Infection in Mice. BioMed research international 2018 (2018)